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708a Wednesday, February 19, 2014protein, called E in flaviviruses. The present work focuses on the dependence of
fusion on membrane composition for the flavivirus Dengue (DEN). Recently it
has been reported that full fusion only occurs with membranes containing
anionic lipids, i.e. late endosomes.1 The origin of this strong dependence on
lipid composition is currently unknown. Regarding cholesterol, different ef-
fects have been reported. One group reported that cholesterol is not absolutely
required but increases the efficiency of fusion of the flavivirus tick-borne en-
cephalitis (TBE) with liposomes.2 Another group reported that an excess of
cholesterol blocks fusion of DEN in mammalian cells.3 Others reported that
fusion of DEN in insect cells was independent of cholesterol.4 To provide
insight into the membrane dependence of fusion for DEN we used several
biophysical techniques (neutron reflectivity, quartz crystal microbalance, den-
sity gradient centrifugation and liposome coflotation analysis) to study the
depth of insertion of E into lipid membranes, the influence of E binding on
membrane curvature, and the anchoring energy of E in the membrane as a func-
tion of membrane composition. Important effects were discovered for both
negatively-charged lipids and cholesterol.
(1) Zaitseva et al PLoS Pathogens 2010, 6, e1001131.
(2) Stiasny et al Journal of Virology 2003, 77, 7856.
(3) Lee, et al Journal of Virology 2008, 82, 6470.
(4) Umashankar et al Journal of Virology 2008, 82, 9245.
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Interferon-induced transmembrane proteins (IFITMs) are up-regulated as part of
a cell’s defense against viral challenges. These small proteins inhibit entry of
diverse viruses, such as influenza A (IAV), West Nile and dengue virus. The
mechanism by which IFITMs block viral entry is not understood. Recent reports
suggest that IFITMs inhibits viral hemifusion (merger of proximal leaflets of the
viral and cellular membranes), presumably by disrupting cholesterol trafficking
and causing aberrant cholesterol accumulation in late endosomes. Here we em-
ployed time-resolved single IAV imaging to identify fusion step(s) affected by
IFITM3 protein ectopically expressed in lung epithelial cells. These experiments
revealed that, contrary to previous reports, lipid mixing between IAV and endo-
somes was, in fact, promoted upon IFITM3 expression. In contrast, virus-cell
fusion assays monitoring the release of the viral content showed marked inhibi-
tion of fusion pore formation by IFITM3. This effect was not due to excessive
cholesterol accumulation in endosomes or to reduced endosome acidity in
IFITM3-expressing cells. Furthermore, conditions that induced the accumulation
of cholesterol in late endosomes/lysosomes did not restrict IAV fusion. To
conclude, IFITM3 blocks IAV fusion by disfavoring the formation of fusion
pores, and this phenomenon is independent of cholesterol levels. We propose
that IFITM3 can block viral fusion at a post-hemifusion stage either directly,
by inserting into and stabilizing the cytosolic leaflet of endosomal membranes,
or indirectly, by altering the lipid composition and thus disfavoring the formation
of fusion pores. This work was partially supported by the NIH R01 GM054787
(to GBM) and 1R01AI091786 (to ALB) grants.
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Targeting membranes of enveloped viruses represents an exciting new para-
digm to explore regarding the development of broad-spectrum antivirals.
Recently, broad-spectrum small-molecule antiviral drugs were described,
which prevent enveloped virus entry at an intermediate step, after virus binding
but before virus-cell fusion [1, 2]. These compounds, an aryl methyldiene rho-
danine derivate, named LJ001, and oxazolidine-2,4-dithione derivates named
JL103 and JL 118, act deleteriously on the virus envelope but not at the cell
membrane level. The aim of the present work was to study the interactions
of active compounds (LJ001, JL103 and JL118) and LJ025 (an inactive analog
used as negative control) with biological membrane models, in order to clarify
the mechanism of action of these new enveloped virus entry inhibitors. Fluores-
cence spectroscopy was used to quantify the partition and determine the loca-
tion of the molecules on membranes. The ability of the compounds to produce
reactive oxygen molecules in the membrane was tested by using 9,10-dimethy-lanthracene, which reacts selectively with singlet oxygen. Changes on the lipid
packing and fluidity of membranes were assessed by fluorescence anisotropy
and generalized polarization measurements. Finally, the ability to inhibit mem-
brane fusion was evaluated using FRET. Our results indicate that singlet oxy-
gen production by LJ001, JL103 and JL118 is able to induce several changes on
membrane properties, specially related with a decrease on its fluidity, concom-
itant with an increase on the order on the polar head groups region, resulting in
an inhibition of the membrane fusion necessary for cell infection.
1. Wolf et al. (2010) PNAS 107, 3157-62.
2. Vigant et al. (2013) PLoS Pathog 9: e1003297.
3591-Pos Board B319
GP41 Ectodomain Dissociates and Forms a Stable Monomer on Phospho-
lipid Vesicles and Detergent Micelles: Implication for the HIV-1 Env-
Mediated Membrane Fusion
Julien Roche, John M. Louis, Ad Bax.
National Institutes of Health, Bethesda, MD, USA.
The first step of HIV infection involves the fusion of the viral and target cell
membranes, a process mediated by the viral envelope glycoproteins, gp120
and gp41. The binding of gp120 to the cell surface receptors CD4 triggers a
cascade of conformational changes that disrupt the gp41-gp120 interactions
and allows the insertion of the N-terminal fusion peptide of gp41 into the
host cell membrane. The gp41 trimer then rapidly folds into a 6-helix bundle
that pulls together the fusion peptide, inserted in the host cell membrane and
the transmembrane domain, located in the viral membrane. Very little structural
information is known about the pre-fusion state of gp41 notwithstanding its
critical importance for the design of fusion inhibitors. To investigate the dy-
namics and structural properties of such metastable states, we designed a set
of protein constructs mimicking the extracellular ectodomain of gp41. We
found that the secondary structure of gp41 ectodomain is pronouncedly
impacted by the presence of phospholipid vesicles or detergents containing
phosphatidyl choline head groups. Our NMR and multi-angle light scattering
data attribute these changes to the transition between a trimer in the absence
of detergent to a monomer in the presence of a membrane-mimicking environ-
ment. The structure of gp41 in a monomeric state was determined by state-of-
the-art NMR techniques, including measurements of NOE distance restraints
and residual dipolar couplings in weakly aligned solutions. 15N relaxation
data provided a detailed view at the backbone dynamics of both the trimeric
and monomeric conformations. This stable monomeric state may represent a
crucial structural intermediate facilitating both the gp41 conformational change
during fusion and the local apposition of the viral and cellular membranes.
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The HIV-1 envelope (Env) glycoprotein, a homotrimeric complex of gp41 and
gp120, mediates attachment and fusion of the HIV-1 virion to its host CD4
cells, the very first and rate-limiting step of HIV infection. The complex holds
gp41 in a largely unfolded high energy state like a loaded spring. The virion
attachment triggers profound conformational rearrangements of Env protein
that couple gp41 folding to membrane fusion by an unknown mechanism. In
this process, gp41 folds from a pre-hairpin structure into a trimer-of-hairpins
structure containing a six-helix bundle. Each hairpin contains an N- and a C-ter-
minal helix linked by a loop. Here, we characterized the energetics and kinetics
of gp41 folding at a single molecule level using high-resolution optical twee-
zers. Our data showed that single gp41 complexes fold in a two-state manner
independent of the solution pH value, releasing extraordinary high energy
competent for membrane fusion. As the sole antigen on the virion surface,
HIV Env complexes are primary targets for anti-HIV drugs and vaccine devel-
opment. Our work will provide important insights into the mechanism of HIV-1
fusion and drug resistance and help improve anti-HIV medicines.
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The HIV-1 virus makes use of a membrane fusion strategy to enter into the
host cell. As such, this process constitutes a clinical target for inhibitor and
